The American Journal of Medicine
Volume 123, Issue 2 , Pages 183.e11-183.e15 , February 2010

Angiotensin-converting Enzyme-related Cough among Chinese-Americans

  • Daniel S. Tseng, MD, MS

      Affiliations

    • Department of Medicine, Kaiser Permanente of Northern California, Santa Clara
    • Corresponding Author InformationRequests for reprints should be addressed to Daniel Tseng, MD, Kaiser Permanente, 710 Lawrence Expressway, Dept 360, Santa Clara, CA 95051
    • ,
  • Jan Kwong, MD

      Affiliations

    • Department of Medicine, Kaiser Permanente of Northern California, Santa Clara
    • ,
  • Firozeh Rezvani, MD

      Affiliations

    • Department of Medicine, Kaiser Permanente of Northern California, Santa Clara
    • ,
  • Ashley O. Coates, MPH

      Affiliations

    • Division of Research, Kaiser Permanente of Northern California, Oakland

References 

  1. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in hypertension. Curr Atheroscler Rep. 2008;10:121–127
  2. Kramer H, Han C, Wendy P, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2004;14:963–970
  3. Jones DW. Hypertension in East Asia. Am J Hypertens. 1995;8:111S–114S
  4. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment and control of hypertension in China. Hypertension. 2002;40:920–927
  5. Ogihara T, Rakugi H. Hypertension in the elderly (A Japanese perspective). Drugs Aging. 2005;22:297–314
  6. Zhou H, Koshakji RP, Silberstein DJ, et al. Racial differences in drug response. N Engl J Med. 1989;320:565–570
  7. Israili ZH, Hall DW. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med. 1992;117:234–242
  8. Woo KS, Norris RM, Nicholls G. Racial differences in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol. 1995;75:967–968
  9. Nishizawa A. Angiotensin-converting enzyme inhibitor induced cough among Asians. Proc UCLA Health. 2000;4:35–38
  10. United States Department of Commerce. United States Census 2000. http://www.census.gov/main/www/cen2000.htmlJuly 2002;
  11. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–710
  12. Quan H, Wang F, Schopflocher D, et al. Development and validation of a surname list to define Chinese ethnicity. Med Care. 2006;44:328–333
  13. Lauderdale DS, Kestenbaum B. Asian American identification by surname. Popul Res Policy Rev. 2000;19:283–300
  14. CIA World Factbook. https://www.cia.gov/library/publications/the-world-factbook/geos/ch.html
  15. Brownstone DM. The Chinese-American Heritage. New York; Oxford, UK: Facts on File; 1988;
  16. Bo W, Hui L, Daru L, et al. Genetic evidence supports demic diffusion of Han culture. Nature. 2004;431:302–304
  17. Gibson GR. Enalapril-induced cough. Arch Intern Med. 1989;149:2701–2703
  18. Strocchi E, Valtancoli G, Ambrosioni E. The incidence of cough during treatment with angiotensin converting enzyme inhibitors. J Hypertens. 1989;7(suppl 6):S308–S309
  19. Tugwell S, Stokes GS. Angiotensin-converting enzyme inhibitor agents and respiratory symptoms. [Letter] Med J Aust. 1987;147:263–264
  20. Perkins RC. Evaluating the Passel-Word Spanish Surname List: 1990 Decennial Census Post Enumeration Survey Results. (Population Division Working Paper No 4) Washington, DC: Population Division, U.S. Bureau of the Census; 1993;
  21. Fiscella K, Fremont A. Use of geocoding and surname analysis to estimate race and ethnicity. Health Serv Res. 2006;41:1482–1500
  22. The hundred families surnames. http://en.wikipedia.org/wiki/Hundred_Family_Surnames
  23. Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893–1906
  24. Strippoli GF, Craig M, Deeks JJ, et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ. 2004;329:828
  25. Barnett AH, Bain SC, Bouter P, et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004;351:1952–1961

 Funding: This study was funded through a grant from the 2008 Community Benefits Research Fund, The Permanente Medical Group.

 Conflict of Interest: All authors state that they are free of any personal or financial association that could represent a conflict of interest regarding the article submitted, and we have respected the research ethics principles.

 Authorship: All authors had access to the data and a role in the writing of the manuscript.

PII: S0002-9343(09)00873-0

doi: 10.1016/j.amjmed.2009.06.032

The American Journal of Medicine
Volume 123, Issue 2 , Pages 183.e11-183.e15 , February 2010

Article Tools